Shares of Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) were up 3.2% during trading on Thursday . The company traded as high as $283.17 and last traded at $282.82. 2,785,628 shares changed hands during mid-day trading, a decline of 48% from the average daily volume of 5,307,264 shares. The stock had previously closed at $274.13.
Analyst Upgrades and Downgrades
A number of analysts have recently weighed in on ALAB shares. Evercore reiterated an "outperform" rating and set a $297.00 price target on shares of Astera Labs in a research report on Tuesday, May 19th. JPMorgan Chase & Co. boosted their price objective on Astera Labs from $205.00 to $280.00 and gave the company an "overweight" rating in a research report on Wednesday, May 6th. Jefferies Financial Group upped their price objective on Astera Labs from $270.00 to $450.00 and gave the stock a "buy" rating in a research note on Wednesday, August 5th. UBS Group reaffirmed a "neutral" rating and issued a $425.00 target price on shares of Astera Labs in a research report on Wednesday, August 5th. Finally, Roth Capital reiterated a "buy" rating and issued a $450.00 target price on shares of Astera Labs in a research note on Wednesday, August 5th. One analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and eight have given a Hold rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $348.33.
Get Our Latest Stock Report on ALAB
Astera Labs Stock Up 3.2%
The firm's 50-day moving average price is $334.67 and its two-hundred day moving average price is $252.89. The firm has a market capitalization of $49.07 billion, a PE ratio of 140.01 and a beta of 3.77.
Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The business had revenue of $392.40 million during the quarter, compared to analysts' expectations of $360.85 million. During the same quarter last year, the firm posted $0.44 earnings per share. Astera Labs's revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities research analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current year.
Insider Transactions at Astera Labs
In other Astera Labs news, Director Stefan A. Dyckerhoff sold 8,994 shares of the firm's stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $311.83, for a total value of $2,804,599.02. Following the sale, the director owned 3,970 shares of the company's stock, valued at $1,237,965.10. This trade represents a 69.38% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 6,801 shares of the company's stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the transaction, the general counsel owned 96,542 shares of the company's stock, valued at approximately $32,872,551. The trade was a 6.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders sold 579,745 shares of company stock worth $206,293,248. 10.40% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Astera Labs
Several institutional investors and hedge funds have recently bought and sold shares of ALAB. California State Teachers Retirement System increased its holdings in shares of Astera Labs by 49,273.2% during the second quarter. California State Teachers Retirement System now owns 100,158,544 shares of the company's stock worth $48,378,580,000 after buying an additional 99,955,684 shares in the last quarter. BlackRock Inc. acquired a new position in shares of Astera Labs in the 2nd quarter worth approximately $6,609,581,000. Atreides Management LP boosted its holdings in shares of Astera Labs by 108.9% in the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company's stock worth $368,890,000 after acquiring an additional 1,754,593 shares in the last quarter. State Street Corp grew its position in Astera Labs by 32.5% during the 4th quarter. State Street Corp now owns 3,099,809 shares of the company's stock worth $515,684,000 after acquiring an additional 760,358 shares during the last quarter. Finally, Geode Capital Management LLC grew its position in Astera Labs by 4.5% during the 4th quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company's stock worth $403,598,000 after acquiring an additional 104,935 shares during the last quarter. Institutional investors own 60.47% of the company's stock.
Astera Labs Company Profile
(
Get Free Report)
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.